A Phase I/II study of vesigenurtacel-l (hs-410) or placebo in combination with Bacillus Calmette-Guerin (BCG) in patients with non-muscle invasive bladder cancer (NMIBC)
Ontology highlight
SUBMITTER: Steinberg G
PROVIDER: S-EPMC4288751 | biostudies-literature | 2014 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA